William Renthal, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Trigeminal Ganglion | 3 | 2024 | 190 | 1.820 |
Why?
|
Nucleus Accumbens | 13 | 2023 | 366 | 1.580 |
Why?
|
Ganglia, Spinal | 2 | 2024 | 526 | 1.350 |
Why?
|
Migraine Disorders | 6 | 2022 | 1700 | 1.270 |
Why?
|
Methyl-CpG-Binding Protein 2 | 4 | 2023 | 187 | 0.950 |
Why?
|
Peripheral Nervous System | 3 | 2022 | 151 | 0.830 |
Why?
|
Rett Syndrome | 3 | 2023 | 164 | 0.790 |
Why?
|
Receptors, Calcitonin Gene-Related Peptide | 1 | 2020 | 31 | 0.710 |
Why?
|
Sensory Receptor Cells | 3 | 2024 | 513 | 0.710 |
Why?
|
Activating Transcription Factor 3 | 1 | 2020 | 59 | 0.700 |
Why?
|
Cocaine | 11 | 2013 | 958 | 0.610 |
Why?
|
Neuroma | 3 | 2024 | 133 | 0.590 |
Why?
|
Neuralgia | 2 | 2023 | 614 | 0.580 |
Why?
|
Proto-Oncogene Proteins c-fos | 9 | 2010 | 586 | 0.580 |
Why?
|
Epigenomics | 1 | 2023 | 942 | 0.570 |
Why?
|
Gene Expression Regulation | 12 | 2020 | 11902 | 0.560 |
Why?
|
Chromatin | 9 | 2023 | 2960 | 0.540 |
Why?
|
Epigenesis, Genetic | 8 | 2017 | 3798 | 0.520 |
Why?
|
Internal Capsule | 1 | 2016 | 138 | 0.490 |
Why?
|
Nociceptors | 3 | 2024 | 461 | 0.480 |
Why?
|
Wernicke Encephalopathy | 1 | 2014 | 29 | 0.460 |
Why?
|
Thiamine Deficiency | 1 | 2014 | 48 | 0.440 |
Why?
|
Central Nervous System | 1 | 2019 | 1337 | 0.400 |
Why?
|
Dopamine Uptake Inhibitors | 7 | 2013 | 297 | 0.380 |
Why?
|
Cocaine-Related Disorders | 4 | 2013 | 461 | 0.350 |
Why?
|
Gene Expression Profiling | 9 | 2024 | 9418 | 0.340 |
Why?
|
Thalamus | 1 | 2016 | 1044 | 0.340 |
Why?
|
Guidelines as Topic | 1 | 2016 | 1385 | 0.330 |
Why?
|
RNA | 2 | 2019 | 2723 | 0.320 |
Why?
|
Histone Deacetylases | 5 | 2009 | 719 | 0.310 |
Why?
|
Brain | 12 | 2023 | 27107 | 0.300 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2014 | 710 | 0.300 |
Why?
|
Substance-Related Disorders | 4 | 2009 | 4420 | 0.300 |
Why?
|
Nervous System Diseases | 1 | 2018 | 1666 | 0.290 |
Why?
|
Amphetamine | 1 | 2008 | 224 | 0.280 |
Why?
|
Genetic Predisposition to Disease | 3 | 2018 | 17912 | 0.280 |
Why?
|
Histones | 9 | 2010 | 2580 | 0.280 |
Why?
|
Mice | 29 | 2024 | 81509 | 0.280 |
Why?
|
Sequence Analysis, RNA | 3 | 2019 | 2020 | 0.270 |
Why?
|
Drug Prescriptions | 1 | 2016 | 1669 | 0.270 |
Why?
|
Neuronal Plasticity | 5 | 2020 | 1435 | 0.270 |
Why?
|
Sirtuins | 1 | 2009 | 320 | 0.270 |
Why?
|
Pain | 2 | 2024 | 5071 | 0.260 |
Why?
|
Neurons | 14 | 2023 | 9462 | 0.240 |
Why?
|
Anorexia Nervosa | 1 | 2014 | 1361 | 0.240 |
Why?
|
Animals | 38 | 2024 | 168441 | 0.230 |
Why?
|
Behavior, Animal | 9 | 2010 | 1878 | 0.230 |
Why?
|
Genomics | 1 | 2020 | 5820 | 0.230 |
Why?
|
Reward | 6 | 2013 | 971 | 0.220 |
Why?
|
Genetic Variation | 1 | 2018 | 6581 | 0.210 |
Why?
|
Single-Cell Analysis | 3 | 2024 | 2449 | 0.210 |
Why?
|
Atlases as Topic | 1 | 2024 | 248 | 0.210 |
Why?
|
Meninges | 1 | 2024 | 198 | 0.200 |
Why?
|
Phantom Limb | 1 | 2023 | 98 | 0.200 |
Why?
|
Antibodies, Monoclonal | 1 | 2019 | 9179 | 0.200 |
Why?
|
DNA Methylation | 6 | 2019 | 4391 | 0.200 |
Why?
|
Stress, Psychological | 6 | 2010 | 4477 | 0.190 |
Why?
|
Axotomy | 1 | 2020 | 71 | 0.180 |
Why?
|
Analgesics, Opioid | 2 | 2016 | 3804 | 0.180 |
Why?
|
Spinal Nerves | 1 | 2020 | 91 | 0.180 |
Why?
|
Species Specificity | 1 | 2024 | 2416 | 0.170 |
Why?
|
Demyelinating Diseases | 1 | 2022 | 351 | 0.170 |
Why?
|
Dendritic Spines | 3 | 2010 | 243 | 0.170 |
Why?
|
Specimen Handling | 1 | 2024 | 702 | 0.160 |
Why?
|
Rats | 10 | 2024 | 23742 | 0.160 |
Why?
|
Mechanoreceptors | 1 | 2020 | 188 | 0.160 |
Why?
|
Analgesia | 1 | 2023 | 461 | 0.160 |
Why?
|
Mice, Inbred C57BL | 18 | 2024 | 22163 | 0.150 |
Why?
|
Acetylation | 4 | 2009 | 1055 | 0.150 |
Why?
|
Chromatin Assembly and Disassembly | 3 | 2008 | 633 | 0.150 |
Why?
|
Depression | 8 | 2010 | 8122 | 0.140 |
Why?
|
Headache | 2 | 2022 | 1256 | 0.140 |
Why?
|
Disease Models, Animal | 9 | 2024 | 18247 | 0.140 |
Why?
|
Pain Measurement | 2 | 2024 | 3550 | 0.140 |
Why?
|
Sciatic Nerve | 1 | 2020 | 616 | 0.140 |
Why?
|
Neuroglia | 1 | 2022 | 955 | 0.130 |
Why?
|
Cornea | 1 | 2024 | 1332 | 0.130 |
Why?
|
Placebos | 1 | 2020 | 1667 | 0.130 |
Why?
|
Brain-Derived Neurotrophic Factor | 4 | 2007 | 602 | 0.130 |
Why?
|
Hypesthesia | 1 | 2016 | 107 | 0.130 |
Why?
|
Constipation | 1 | 2020 | 562 | 0.130 |
Why?
|
Mosaicism | 1 | 2018 | 475 | 0.120 |
Why?
|
Humans | 29 | 2024 | 761423 | 0.120 |
Why?
|
Nerve Regeneration | 1 | 2020 | 795 | 0.120 |
Why?
|
Repressor Proteins | 2 | 2019 | 2985 | 0.120 |
Why?
|
Imipramine | 3 | 2009 | 98 | 0.120 |
Why?
|
Nervous System | 2 | 2008 | 545 | 0.110 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2009 | 1171 | 0.110 |
Why?
|
Morphine Dependence | 1 | 2013 | 27 | 0.110 |
Why?
|
PC12 Cells | 3 | 2009 | 317 | 0.110 |
Why?
|
Stroke | 1 | 2016 | 9756 | 0.110 |
Why?
|
Muscle Weakness | 1 | 2016 | 412 | 0.110 |
Why?
|
Thiamine | 1 | 2014 | 160 | 0.110 |
Why?
|
Oligonucleotide Array Sequence Analysis | 6 | 2013 | 3779 | 0.100 |
Why?
|
Adaptation, Physiological | 3 | 2008 | 1301 | 0.100 |
Why?
|
Social Behavior | 3 | 2010 | 1134 | 0.100 |
Why?
|
Axons | 1 | 2020 | 1674 | 0.100 |
Why?
|
Sirtuin 1 | 1 | 2013 | 246 | 0.100 |
Why?
|
Narcotics | 3 | 2013 | 336 | 0.100 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2023 | 1860 | 0.100 |
Why?
|
Lumbar Vertebrae | 1 | 2020 | 1881 | 0.090 |
Why?
|
Dopamine | 3 | 2007 | 1605 | 0.090 |
Why?
|
Brain Concussion | 1 | 2022 | 1404 | 0.090 |
Why?
|
Serum Response Factor | 1 | 2010 | 78 | 0.090 |
Why?
|
Transcription Factors | 3 | 2023 | 12125 | 0.090 |
Why?
|
H-2 Antigens | 1 | 2010 | 358 | 0.090 |
Why?
|
Transcription, Genetic | 3 | 2019 | 7595 | 0.090 |
Why?
|
Recovery of Function | 1 | 2020 | 2977 | 0.090 |
Why?
|
Morphine | 3 | 2013 | 656 | 0.090 |
Why?
|
Dominance-Subordination | 4 | 2010 | 26 | 0.080 |
Why?
|
Antidepressive Agents | 4 | 2010 | 2897 | 0.080 |
Why?
|
Promoter Regions, Genetic | 3 | 2009 | 5789 | 0.080 |
Why?
|
Extremities | 1 | 2014 | 867 | 0.080 |
Why?
|
Myogenic Regulatory Factors | 1 | 2008 | 103 | 0.080 |
Why?
|
Conditioning, Operant | 2 | 2006 | 310 | 0.080 |
Why?
|
Veterans | 1 | 2022 | 2647 | 0.080 |
Why?
|
Drug Administration Schedule | 4 | 2008 | 4852 | 0.070 |
Why?
|
Histone Deacetylase 1 | 1 | 2008 | 133 | 0.070 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2009 | 774 | 0.070 |
Why?
|
Alleles | 1 | 2018 | 6922 | 0.070 |
Why?
|
Signal Transduction | 5 | 2013 | 23441 | 0.070 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2009 | 432 | 0.070 |
Why?
|
Down-Regulation | 3 | 2010 | 2918 | 0.070 |
Why?
|
Emotions | 2 | 2010 | 2739 | 0.070 |
Why?
|
Genome-Wide Association Study | 3 | 2019 | 12688 | 0.070 |
Why?
|
Feedback, Physiological | 1 | 2009 | 476 | 0.070 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2009 | 502 | 0.070 |
Why?
|
Motor Activity | 4 | 2010 | 2711 | 0.070 |
Why?
|
Male | 25 | 2024 | 360736 | 0.070 |
Why?
|
Social Environment | 1 | 2010 | 1020 | 0.060 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2010 | 682 | 0.060 |
Why?
|
Acute Disease | 1 | 2016 | 7238 | 0.060 |
Why?
|
Electrophysiology | 1 | 2008 | 1262 | 0.060 |
Why?
|
Mesencephalon | 1 | 2006 | 332 | 0.060 |
Why?
|
Brain Chemistry | 1 | 2008 | 959 | 0.060 |
Why?
|
Rats, Long-Evans | 3 | 2010 | 383 | 0.060 |
Why?
|
Zymosan | 1 | 2024 | 136 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8000 | 0.060 |
Why?
|
Benzamides | 1 | 2009 | 1370 | 0.060 |
Why?
|
Enzyme Inhibitors | 3 | 2009 | 3712 | 0.060 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 2024 | 133 | 0.050 |
Why?
|
Limbic System | 1 | 2006 | 419 | 0.050 |
Why?
|
RNA, Messenger | 5 | 2010 | 12796 | 0.050 |
Why?
|
Molar | 1 | 2024 | 156 | 0.050 |
Why?
|
Dental Pulp | 1 | 2024 | 84 | 0.050 |
Why?
|
Receptors, Opioid | 1 | 2023 | 145 | 0.050 |
Why?
|
Mice, Knockout | 5 | 2023 | 14409 | 0.050 |
Why?
|
Behavior, Addictive | 1 | 2008 | 462 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2013 | 4575 | 0.050 |
Why?
|
Resilience, Psychological | 1 | 2010 | 788 | 0.050 |
Why?
|
Thrombospondin 1 | 1 | 2024 | 257 | 0.050 |
Why?
|
Protein Transport | 1 | 2008 | 1966 | 0.050 |
Why?
|
Receptors, Opioid, mu | 1 | 2023 | 167 | 0.050 |
Why?
|
Macaca | 1 | 2023 | 412 | 0.050 |
Why?
|
Frontal Lobe | 1 | 2008 | 1420 | 0.050 |
Why?
|
Neuroimmunomodulation | 1 | 2024 | 181 | 0.050 |
Why?
|
Methylation | 3 | 2010 | 1083 | 0.050 |
Why?
|
Biology | 1 | 2023 | 289 | 0.050 |
Why?
|
Mice, Transgenic | 3 | 2009 | 9535 | 0.050 |
Why?
|
DNA Repair Enzymes | 1 | 2002 | 346 | 0.050 |
Why?
|
Protein Processing, Post-Translational | 1 | 2009 | 1974 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2016 | 12970 | 0.050 |
Why?
|
NF-kappa B | 1 | 2009 | 2488 | 0.040 |
Why?
|
Hospitalization | 1 | 2020 | 10718 | 0.040 |
Why?
|
Transgenes | 1 | 2023 | 1010 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 5 | 2010 | 8179 | 0.040 |
Why?
|
Brain Diseases | 1 | 2008 | 1545 | 0.040 |
Why?
|
Corpus Striatum | 1 | 2005 | 1235 | 0.040 |
Why?
|
Up-Regulation | 1 | 2008 | 4124 | 0.040 |
Why?
|
Neuropeptides | 1 | 2005 | 944 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2018 | 15941 | 0.040 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2013 | 855 | 0.040 |
Why?
|
Peptides | 1 | 2010 | 4345 | 0.040 |
Why?
|
Synapses | 2 | 2023 | 1769 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2006 | 2871 | 0.040 |
Why?
|
Benzhydryl Compounds | 1 | 2005 | 916 | 0.040 |
Why?
|
Self Administration | 2 | 2010 | 390 | 0.040 |
Why?
|
Wakefulness | 1 | 2005 | 1265 | 0.040 |
Why?
|
Documentation | 1 | 2024 | 897 | 0.040 |
Why?
|
Pyridines | 1 | 2009 | 2875 | 0.040 |
Why?
|
Mutation | 2 | 2019 | 30045 | 0.040 |
Why?
|
Neostriatum | 2 | 2008 | 246 | 0.040 |
Why?
|
Computational Biology | 1 | 2009 | 3517 | 0.030 |
Why?
|
Chronic Disease | 2 | 2010 | 9320 | 0.030 |
Why?
|
Central Nervous System Stimulants | 1 | 2005 | 1176 | 0.030 |
Why?
|
Immunoprecipitation | 2 | 2010 | 878 | 0.030 |
Why?
|
Ventral Tegmental Area | 2 | 2007 | 136 | 0.030 |
Why?
|
Phosphorylation | 2 | 2023 | 8320 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2009 | 10766 | 0.030 |
Why?
|
Social Isolation | 2 | 2009 | 364 | 0.030 |
Why?
|
Cognition Disorders | 1 | 2008 | 3979 | 0.030 |
Why?
|
Fluoxetine | 2 | 2009 | 733 | 0.030 |
Why?
|
Aged | 4 | 2024 | 169235 | 0.030 |
Why?
|
Sirtuin 2 | 1 | 2013 | 95 | 0.030 |
Why?
|
Hippocampus | 1 | 2006 | 3763 | 0.030 |
Why?
|
Opioid-Related Disorders | 1 | 2008 | 2162 | 0.030 |
Why?
|
DNA Damage | 1 | 2002 | 2446 | 0.030 |
Why?
|
Immunohistochemistry | 4 | 2008 | 11073 | 0.030 |
Why?
|
Female | 6 | 2024 | 392581 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2017 | 1756 | 0.020 |
Why?
|
Neutrophils | 1 | 2024 | 3766 | 0.020 |
Why?
|
Blotting, Western | 2 | 2010 | 5036 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2002 | 3447 | 0.020 |
Why?
|
Mice, Inbred AKR | 1 | 2010 | 104 | 0.020 |
Why?
|
Helplessness, Learned | 1 | 2010 | 28 | 0.020 |
Why?
|
Enzyme Repression | 1 | 2010 | 30 | 0.020 |
Why?
|
Skin | 1 | 2024 | 4481 | 0.020 |
Why?
|
Immunoblotting | 1 | 2013 | 1647 | 0.020 |
Why?
|
Analysis of Variance | 2 | 2009 | 6231 | 0.020 |
Why?
|
Genes, MHC Class I | 1 | 2010 | 240 | 0.020 |
Why?
|
Postmortem Changes | 1 | 2009 | 119 | 0.020 |
Why?
|
Histone Deacetylase 2 | 1 | 2009 | 72 | 0.020 |
Why?
|
Mice, Inbred C3H | 1 | 2010 | 915 | 0.020 |
Why?
|
Macrophages | 1 | 2024 | 5768 | 0.020 |
Why?
|
CREB-Binding Protein | 1 | 2009 | 148 | 0.020 |
Why?
|
Sucrose | 1 | 2009 | 158 | 0.020 |
Why?
|
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 2008 | 19 | 0.020 |
Why?
|
United States | 1 | 2016 | 72339 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2002 | 5794 | 0.020 |
Why?
|
Central Nervous System Depressants | 1 | 2008 | 164 | 0.020 |
Why?
|
Mental Disorders | 1 | 2007 | 6841 | 0.020 |
Why?
|
Inhibitory Concentration 50 | 1 | 2008 | 465 | 0.020 |
Why?
|
Sweetening Agents | 1 | 2009 | 290 | 0.020 |
Why?
|
Oncogene Protein v-akt | 1 | 2006 | 129 | 0.020 |
Why?
|
Hydroxamic Acids | 1 | 2009 | 481 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2010 | 2265 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2014 | 36423 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2017 | 3612 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2024 | 20093 | 0.020 |
Why?
|
DNA Primers | 1 | 2010 | 2820 | 0.020 |
Why?
|
Gene Expression | 2 | 2009 | 7584 | 0.020 |
Why?
|
Food Preferences | 1 | 2009 | 398 | 0.020 |
Why?
|
Locus Coeruleus | 1 | 2008 | 230 | 0.020 |
Why?
|
DNA | 1 | 2019 | 7219 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2010 | 1699 | 0.020 |
Why?
|
Adolescent | 1 | 2014 | 88313 | 0.020 |
Why?
|
Alternative Splicing | 1 | 2010 | 1093 | 0.020 |
Why?
|
Lysine | 1 | 2010 | 992 | 0.020 |
Why?
|
Cyclin-Dependent Kinase 5 | 1 | 2005 | 112 | 0.020 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2008 | 655 | 0.020 |
Why?
|
Butyrates | 1 | 2005 | 169 | 0.020 |
Why?
|
Cell Size | 1 | 2006 | 624 | 0.010 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2006 | 557 | 0.010 |
Why?
|
Hallucinogens | 1 | 2008 | 197 | 0.010 |
Why?
|
Inflammation | 1 | 2024 | 10762 | 0.010 |
Why?
|
Cyclic AMP | 1 | 2008 | 1463 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2022 | 15838 | 0.010 |
Why?
|
Acid Anhydride Hydrolases | 1 | 2002 | 67 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2009 | 18964 | 0.010 |
Why?
|
Middle Aged | 3 | 2024 | 220826 | 0.010 |
Why?
|
Adult | 3 | 2024 | 221148 | 0.010 |
Why?
|
Narcolepsy | 1 | 2005 | 199 | 0.010 |
Why?
|
Protein Subunits | 1 | 2005 | 943 | 0.010 |
Why?
|
Models, Biological | 2 | 2009 | 9469 | 0.010 |
Why?
|
Interpersonal Relations | 1 | 2009 | 1436 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 13361 | 0.010 |
Why?
|
Radiation, Ionizing | 1 | 2002 | 251 | 0.010 |
Why?
|
Ethanol | 1 | 2008 | 1324 | 0.010 |
Why?
|
S Phase | 1 | 2002 | 421 | 0.010 |
Why?
|
Sleep, REM | 1 | 2005 | 594 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 2002 | 868 | 0.010 |
Why?
|
Aggression | 1 | 2006 | 750 | 0.010 |
Why?
|
Drug Interactions | 1 | 2005 | 1414 | 0.010 |
Why?
|
Time Factors | 3 | 2008 | 39975 | 0.010 |
Why?
|
Gene Transfer Techniques | 1 | 2005 | 1206 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2002 | 1435 | 0.010 |
Why?
|
Prospective Studies | 1 | 2024 | 54415 | 0.010 |
Why?
|
Base Sequence | 1 | 2010 | 12450 | 0.010 |
Why?
|
Environment | 1 | 2005 | 1122 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2024 | 58956 | 0.010 |
Why?
|
Gene Silencing | 1 | 2005 | 1509 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2010 | 13449 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2010 | 17644 | 0.010 |
Why?
|
Phosphoproteins | 1 | 2006 | 2448 | 0.010 |
Why?
|
Genome | 1 | 2005 | 1740 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2007 | 4287 | 0.010 |
Why?
|
HeLa Cells | 1 | 2002 | 3093 | 0.010 |
Why?
|
Anxiety | 1 | 2010 | 4572 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2002 | 3792 | 0.010 |
Why?
|
Models, Molecular | 1 | 2005 | 5439 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2002 | 6132 | 0.010 |
Why?
|
Attention | 1 | 2005 | 2395 | 0.010 |
Why?
|
DNA Repair | 1 | 2002 | 2045 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2022 | 80582 | 0.010 |
Why?
|
Cell Survival | 1 | 2002 | 5790 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2002 | 2803 | 0.010 |
Why?
|
Apoptosis | 1 | 2006 | 9488 | 0.010 |
Why?
|
Genotype | 1 | 2005 | 13009 | 0.010 |
Why?
|
Electroencephalography | 1 | 2005 | 6224 | 0.010 |
Why?
|
Pregnancy | 1 | 2010 | 29862 | 0.000 |
Why?
|
DNA-Binding Proteins | 1 | 2002 | 9606 | 0.000 |
Why?
|